Oncology

Merck Bolsters Oncology Portfolio with $680 Mn Acquisition of Harpoon Therapeutics January 9, 2024 The move is pivotal for Merck as it seeks alternative revenue streams, considering potential pricing pressure on its top-selling medicine, the cancer immunotherapy Keytruda.

Healthtech Startup Mestastop Solutions Partners Vipragen Biosciences to Enhance Oncology Services December 27, 2023 The collaboration aimed to elevate Vipragen's global oncology services using Mestastop's proprietary platforms.

Venus Remedies Expands its Oncology Portfolio in South Eastern Europe September 22, 2023 Haryana-based Venus Remedies Ltd, a pharmaceutical company specialising in oncology treatments, has recently received marketing authorisation in Serbia for two essential chemotherapy drugs, gemcitabine and docetaxel.